Mas‐Related G Protein‐Coupled Receptor Member D Sustains Hypertension
MedComm · 2026-04 · 7 (4)
DOI: 10.1002/mco2.70706 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 28.03.2026. Verfasst von Kun Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu Province China. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hypertension and its associated complications, including vascular remodeling, pose a major burden on global public health. However, the role of Mas‐related G protein‐coupled receptor member D (MrgD) in hypertension remains incompletely understood. In this study, we observed upregulated MrgD expression in the arterial tissues of hypertensive patients and animal models. In Sprague‐Dawley rats, MrgD overexpression elevated blood pressure (BP) and promoted mesenteric vascular remodeling, whereas MrgD knockdown in spontaneously hypertensive rats normalized BP and ameliorated vascular remodeling. Consistently, MrgD knockout mice exhibited resistance to angiotensin II (Ang II)‐induced hypertension and vascular injury. Mechanistic investigations demonstrated that MrgD facilitated vascular remodeling in vascular smooth muscle cells (VSMCs) through the voltage‐gated L‐type Ca 2 + channel (Cav1.2)‐Ca 2 + /calmodulin‐dependent protein kinase IIγ (CaMKIIγ) signaling axis. Co‐immunoprecipitation coupled with mass spectrometry and in vitro functional assays confirmed that Ang II enhanced the interaction among MrgD, CaMKIIγ, and Cav1.2, thereby promoting VSMC phenotypic switch. Through artificial intelligence‐driven screening combined with functional validation, we identified risperidone as a small‐molecule inhibitor of MrgD that effectively attenuated hypertension and vascular remodeling. These findings established MrgD as a key contributor to the pathogenesis of hypertension and underscore its potential as a promising therapeutic target for hypertension and its associated vascular complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu Province China.
- Duofortunatherapeutic Suzhou Co. Ltd. Suzhou Jiangsu Province China.
- Department of Cardiothoracic Surgery The Second Affiliated Hospital of Soochow University Suzhou Jiangsu Province China.
- Department of Cardiovascular Surgery The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu Province China.
- Department of Cardiology Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital Fuzhou, Fujian Province China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, K., Hua, D., Mao, Y., Wu, X., Gao, M., Song, S., Chen, L., Zheng, X., & Li, P. (2026). Mas‐Related G Protein‐Coupled Receptor Member D Sustains Hypertension. MedComm, 7(4). https://doi.org/10.1002/mco2.70706
Vancouver
Zhao K, Hua D, Mao Y, Wu X, Gao M, Song S, et al. Mas‐Related G Protein‐Coupled Receptor Member D Sustains Hypertension. MedComm. 2026;7(4). doi:10.1002/mco2.70706
BibTeX
@article{Zhao2026,
author = {Zhao, Kun and Hua, Dongxu and Mao, Yukang and Wu, Xiaoguang and Gao, Min and Song, Shidong and Chen, Lei and Zheng, Xiangxiang and Li, Peng},
title = {Mas‐Related G Protein‐Coupled Receptor Member D Sustains Hypertension},
journal = {MedComm},
year = {2026},
volume = {7},
number = {4},
doi = {10.1002/mco2.70706}
}
EUVIMED